Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
11.50
+0.08 (0.70%)
Jun 24, 2026, 1:09 PM EDT - Market open
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $949.59 million as of June 24, 2026. Its market cap has increased by 26.34% in one year.
Market Cap
949.59M
Enterprise Value
756.79M
1-Year Change
26.34%
Ranking
Category
Stock Price
$11.50
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $949.59M, an increase of 103.11%. That is a compound annual growth rate of 9.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 923.16M | 21.08% |
| Dec 31, 2025 | 762.47M | -18.18% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seaport Therapeutics | 963.01M |
| Lexicon Pharmaceuticals | 955.02M |
| DBV Technologies | 942.13M |
| ORIC Pharmaceuticals | 924.41M |
| Kura Oncology | 919.70M |
| Pharming Group | 917.37M |
| Alpha Tau Medical | 904.47M |
| Avalo Therapeutics | 897.82M |